Omnicell
OMCL Small CapHealthcare · Health Information Services
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Omnicell Stock at a Glance
Omnicell (OMCL) is currently trading at 36,51 € with a market capitalization of 1,7 Mrd. €. The trailing P/E ratio stands at 97.27x, with a forward P/E of 19.5x. The 52-week range spans from 19,33 € to 46,92 €; the current price is 22.2% below the yearly high. Year-over-year revenue growth stands at +14.9%. The net profit margin stands at 1.67%.
💰 Dividendo
Omnicell currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Raccomandazioni degli Analisti
7 analysts rate Omnicell (OMCL) on consensus: Acquisto Forte. The average price target is 52,28 €, implying +43.19% from the current price. Analyst price targets range from 46,92 € to 59,71 €.
Tesi di Investimento: Punti di Forza e Debolezze
- Analyst consensus: Strong Buy
- Solid balance sheet with low debt (D/E 15.16)
- Positive free cash flow
- –Low profitability (1.67% margin)
- –High valuation multiple (P/E 97.27x)
- –Currently flagged as overvalued
Panoramica Tecnica
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior, elevated short interest (6.73%).
Dati di Trading
Azioni Correlate nello Stesso Settore
Where can I buy Omnicell?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
